Toghill BJ, Saratzis A, Bown MJ. Abdominal aortic aneurysm – an independent disease to atherosclerosis?. Cardiovasc Pathol. 2017;27:71–5.
Saratzis A, Dattani N, Brown A. Multi-centre study on cardiovascular risk management on patients undergoing AAA surveillance. Eur J Vasc Endovasc Surg. 2017;54(1):116–22.
Toghill BJ, Saratzis A, Harrison SC, Verissimo AR, Mallon EB, Bown MJ. The potential role of DNA methylation in the pathogenesis of abdominal aortic aneurysm. Atherosclerosis. 2015;241(1):121–9.
Saratzis A, Bown MJ. The genetic basis for aortic aneurysmal disease. Heart. 2014;100(12):916–22.
Michel JB, Martin-Ventura JL, Egido J. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res. 2011;90(1):18–27.
Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol. 2007;27(6):1259–68.
Michel JB, Ho-Tin-Noe B. Thrombi and neutrophils. Circ Res. 2015;116(7):1107–8.
Michel JB, Lattion AL, Salzmann JL. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res. 1988;62(4):641–50.
Allenspach-Petrzilka GE, Guggenheim B. Bacterial invasion of the periodontium: an important factor in the pathogenesis of periodontitis?. J Clin Periodontol. 1983;10(6):609–17.
van Palenstein Helderman WH. Microbial etiology of periodontal disease. J Clin Periodontol. 1981;8(4):261–80.
van Winkelhoff AJ, de Graaff J. Microbiology in the management of destructive periodontal disease. J Clin Periodontol. 1991;18(6):406–10.
Eke PI, Wei L, Borgnakke WS. Periodontitis prevalence in adults >/= 65 years of age, in the USA. Periodontol 2000. 2016;72(1):76–95.
Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72–80.
Dzink JL, Tanner AC, Haffajee AD, Socransky SS. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol. 1985;12(8):648–59.
Haffajee AD, Socransky SS, Smith C, Dibart S. Relation of baseline microbial parameters to future periodontal attachment loss. J Clin Periodontol. 1991;18(10):744–50.
Listgarten MA, Levin S. Positive correlation between the proportions of subgingival spirochetes and motile bacteria and susceptibility of human subjects to periodontal deterioration. J Clin Periodontol. 1981;8(2):122–38.
Offenbacher S, Odle B, van Dyke T. The microbial morphotypes associated with periodontal health and adult periodontitis: composition and distribution. J Clin Periodontol. 1985;12(9):736–49.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–44.
Socransky SS, Haffajee AD, Smith C, Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J Clin Periodontol. 1991;18(10):766–75.
Kinane DF, Zhang P, Benakanakere M. Experimental gingivitis, bacteremia and systemic biomarkers: a randomized clinical trial. J Periodontal Res. 2015;50(6):864–9.
Kinane DF, Cullen CF, Johnston FA, Evans CW. Neutrophil chemotactic behaviour in patients with early-onset forms of periodontitis (I). Leading front analysis in Boyden chambers. J Clin Periodontol. 1989;16(4):242–6.
Kinane DF, Cullen CF, Johnston FA, Evans CW. Neutrophil chemotactic behaviour in patients with early-onset forms of periodontitis (II). Assessment using the under agarose technique. J Clin Periodontol. 1989;16(4):247–51.
Zafiropoulos GG, Flores-de-Jacoby L, Plate VM, Eckle I, Kolb G. Polymorphonuclear neutrophil chemiluminescence in periodontal disease. J Clin Periodontol. 1991;18(8):634–9.
Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodontal Res. 2002;37(3):196–203.
Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol. 2003;74(2):188–95.
Dong W, Xiang J, Li C, Cao Z, Huang Z. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis. J Periodontal Res. 2009;44(1):125–32.
Sorsa T, Gursoy UK, Nwhator S. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000. 2016;70(1):142–63.
Sorsa T, Tjaderhane L, Konttinen YT. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38(5):306–21.
Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2015;69(1):7–17.
Emingil G, Han B, Gurkan A. Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy. J Periodontol. 2014;85(8):1070–80.
Sapna G, Gokul S, Bagri-Manjrekar K. Matrix metalloproteinases and periodontal diseases. Oral Dis. 2014;20(6):538–50.
Ruggiero S, Cosgarea R, Potempa J, Potempa B, Eick S, Chiquet M. Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C. Biochim Biophys Acta. 2013;1832(4):517–26.
Letra A, Silva RM, Rylands RJ. MMP3 and TIMP1 variants contribute to chronic periodontitis and may be implicated in disease progression. J Clin Periodontol. 2012;39(8):707–16.
Sorsa T, Tervahartiala T, Leppilahti J. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res. 2011;63(2):108–13.
Sorsa T, Mantyla P, Tervahartiala T, Pussinen PJ, Gamonal J, Hernandez M. MMP activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol. 2011;38(9):817–9.
Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res. 1997;32(1 Pt 2):120–5.
Suzuki JI, Aoyama N, Ogawa M. Periodontitis and cardiovascular diseases. Expert Opin Therapeutic Targets. 2010;14(10):1023–7.
Lee YL, Hu HY, Huang N, Hwang DK, Chou P, Chu D. Dental prophylaxis and periodontal treatment are protective factors to ischemic stroke. Stroke. 2013;44(4):1026–30.
Tonetti MS, Van Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol. 2013;84(suppl 4):S24–S29.
Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol. 2009;36(suppl 10):15–9.
Bartova J, Sommerova P, Lyuya-Mi Y. Periodontitis as a risk factor of atherosclerosis. J Immunol Res. 2014;2014:636893.
Geerts SO, Nys M, De MP. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002;73(1):73–8.
Gaetti-Jardim E, JrMarcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol. 2009;58(Pt 12):1568–75.
Wada K, Kamisaki Y. Roles of oral bacteria in cardiovascular diseases – from molecular mechanisms to clinical cases: involvement of Porphyromonas gingivalis in the development of human aortic aneurysm. J Pharmacol Sci. 2010;113(2):115–9.
Boillot A, Demmer RT, Mallat Z. Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Atherosclerosis. 2015;242(2):418–23.
Mahalakshmi K, Krishnan P, Arumugam SB. Association of periodontopathic anaerobic bacterial co-occurrence to atherosclerosis – a cross-sectional study. Anaerobe. 2017;44:66–72.
Szulc M, Kustrzycki W, Janczak D, Michalowska D, Baczynska D, Radwan-Oczko M. Presence of periodontopathic bacteria DNA in atheromatous plaques from coronary and carotid arteries. Biomed Res Int. 2015;2015:825397.
Rath SK, Mukherjee M, Kaushik R, Sen S, Kumar M. Periodontal pathogens in atheromatous plaque. Indian J Pathol Microbiol. 2014;57(2):259–64.
Figuero E, Sanchez-Beltran M, Cuesta-Frechoso S. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol. 2011;82(10):1469–77.
Zaremba M, Gorska R, Suwalski P, Kowalski J. Evaluation of the incidence of periodontitis-associated bacteria in the atherosclerotic plaque of coronary blood vessels. J Periodontol. 2007;78(2):322–7.
Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Periodontol. 2013;84(suppl 4):S1–S7.
Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol. 2003;23(7):1245–9.
Elter JR, Hinderliter AL, Offenbacher S. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J. 2006;151(1):47.
Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34–45.
Massberg S, Grahl L, von Bruehl ML. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16(8):887–96.
Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123(18):2768–76.
Thoden van Velzen SK, Abraham-Inpijn L, Moorer WR. Plaque and systemic disease: a reappraisal of the focal infection concept. J Clin Periodontol. 1984;11(4):209–20.
Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13:547–58.
Aoyama N, Suzuki J, Wang D. Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res. 2011;46(2):176–83.
Alsac JM, Delbosc S, Rouer M. Fucoidan interferes with Porphyromonas gingivalis-induced aneurysm enlargement by decreasing neutrophil activation. J Vasc Surg. 2013;57(3):796–805.
Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, Ishikawa I. Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2004;28(5):553–8.
Marques da Silva R, Caugant DA, Lingaas PS, Geiran O, Tronstad L, Olsen I. Detection of Actinobacillus actinomycetemcomitans but not bacteria of the red complex in aortic aneurysms by multiplex polymerase chain reaction. J Periodontol. 2005;76(4):590–4.
Nakano K, Wada K, Nomura R. Characterization of aortic aneurysms in cardiovascular disease patients harboring Porphyromonas gingivalis. Oral Dis. 2011;17(4):370–8.
Suzuki J, Aoyama N, Aoki M. High incidence of periodontitis in Japanese patients with abdominal aortic aneurysm. Int Heart J. 2014;55(3):268–70.
Halme S, Juvonen T, Laurila A. Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest. 1999;29(6):546–52.
Lindholt JS, Juul S, Vammen S, Lind I, Fasting H, Henneberg EW. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg. 1999;86(5):634–8.
Karlsson L, Gnarpe J, Naas J. Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2000;19(6):630–5.
Liberati A, Altman DG, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Richardson WS. On questions, background and foreground. In: Wilson MC, ed. Evidence Based Healthcare Newsletter; 1997;17:8–9.
Shea BJ, Grimshaw JM, Wells GA. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.
Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA. Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect. 2014;122(7):711–8.
Aoyama N, Suzuki J, Ogawa M. Toll-like receptor-2 plays a fundamental role in periodontal bacteria-accelerated abdominal aortic aneurysms. Circ J. 2013;77(6):1565–73.
Delbosc S, Alsac JM, Journe C. Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS One. 2011;6(4):e18679.
Fontaine V, Touat Z, Mtairag el M. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol. 2004;164(6):2077–87.
Houard X, Touat Z, Ollivier V. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res. 2009;82(3):532–41.
Aoyama N, Suzuki JI, Ogawa M. A periodontal pathogen accelerates the progression of abdominal aortic aneurysm via toll-like receptor-2 signaling. Circulation. 2018;124:A9403.
Sasajima T, Takano Y, Hiraishi Y. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system. J Vasc Surg. 2000;32(2):374–82.
Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T. Plasma tissue plasminogen activator and abdominal aortic aneurysm presence: a systematic review and meta-analysis. Ann Vasc Surg. 2010;24(5):686–9.
Amano A. Host–parasite interactions in periodontitis: microbial pathogenicity and innate immunity. Periodontol 2000. 2010;54(1):9–14.
Amano A. Host–parasite interactions in periodontitis: subgingival infection and host sensing. Periodontol 2000. 2010;52(1):7–11.
Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000. 2006;40:77–93.
Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006;33(6):401–7.
Maharaj B, Coovadia Y, Vayej AC. An investigation of the frequency of bacteraemia following dental extraction, tooth brushing and chewing. Cardiovasc J Afr. 2012;23(6):340–4.
Craig RG, Pernat AM, Pecoits-Filho R, Levin NW, Kotanko P. Periodontal diseases and systemic inflammation. Semin Dial. 2013;26(1):23–8.
Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Clin Periodontol. 2013;40(suppl 14):S1–S7.
Linden GJ, Herzberg MC. Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(suppl 14):S20–S23.
Papapanou PN. Systemic effects of periodontitis: lessons learned from research on atherosclerotic vascular disease and adverse pregnancy outcomes. Int Dent J. 2015;65(6):283–91.
Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol. 2007;78(12):2289–302.
Abariga SA, Whitcomb BW. Periodontitis and gestational diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Pregnancy Childbirth. 2016;16(1):344.
Wang TF, Jen IA, Chou C, Lei YP. Effects of periodontal therapy on metabolic control in patients with type 2 diabetes mellitus and periodontal disease: a meta-analysis. Medicine (Baltimore). 2014;93(28):e292.
Armingohar Z, Jorgensen JJ, Kristoffersen AK, Abesha-Belay E, Olsen I. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. J Oral Microbiol. 2014;6. doi:10.3402/jom.v6.23408.
Tonetti MS, Van Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(suppl 14):S24–S29.
Figuero E, Lindahl C, Marín MJ. Quantification of periodontal pathogens in vascular, blood, and subgingival samples from patients with peripheral arterial disease or abdominal aortic aneurysms. J Periodontol. 2014;85(9):1182–93.
Olsen I, Progulske-Fox A. Invasion of Porphyromonas gingivalis strains into vascular cells and tissue. J Oral Microbiol. 2015;7:28788.
Belanger M, Kozarov E, Song H, Whitlock J, Progulske-Fox A. Both the unique and repeat regions of the Porphyromonas gingivalis hemagglutin A are involved in adhesion and invasion of host cells. Anaerobe. 2012;18(1):128–34.
Liu F, Wang Y, Xu J, Hu R, Deng H. Effects of Porphyromonas gingivalis lipopolysaccharide on the expression of key genes involved in cholesterol metabolism in macrophages. Arch Med Sci. 2016;12(5):959–67.
Delbosc S, Rouer M, Alsac JM. High-density lipoprotein therapy inhibits Porphyromonas gingivalis-induced abdominal aortic aneurysm progression. Thromb Haemost. 2016;115(4):789–99.
Li XY, Wang C, Xiang XR, Chen FC, Yang CM, Wu J. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages. Oncol Rep. 2013;30(3):1329–36.
Jaramillo A, Lafaurie GI, Millan LV. Association between periodontal disease and plasma levels of cholesterol and triglycerides. Colomb Med (Cali). 2013;44(2):80–6.
Maekawa T, Takahashi N, Tabeta K. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One. 2011;6(5):e20240.
Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog. 2003;35(6):259–67.
Paraskevas KI, Mikhailidis DP, Giannoukas AD. Periodontitis and abdominal aortic aneurysms: a random association or a pathogenetic link?. Int Angiol. 2009;28(6):431–3.
Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg. 2000;32(3):575–83.
Dawson J, Cockerill G, Choke E, Loftus I, Thompson MM. Circulating cytokines in patients with abdominal aortic aneurysms. Ann N Y Acad Sci. 2006;1085:324–6.
Wallinder J, Bergqvist D, Henriksson AE. Proinflammatory and anti-inflammatory cytokine balance in patients with abdominal aortic aneurysm and the impact of aneurysm size. Vasc Endovasc Surg. 2009;43(3):258–61.
Petersen E, Wagberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg. 2002;23(2):153–7.
Kadoglou NP, Liapis CD. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin. 2004;20(4):419–32.
Palombo D, Maione M, Cifiello BI, Udini M, Maggio D, Lupo M. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg (Torino). 1999;40(2):257–60.
Courtois A, Nusgens BV, Hustinx R. 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J Nucl Med. 2013;54(10):1740–7.
Folkesson M, Silveira A, Eriksson P, Swedenborg J. Protease activity in the multi-layered intra-luminal thrombus of abdominal aortic aneurysms. Atherosclerosis. 2011;218(2):294–9.
Kim HW, Blomkalns AL, Ogbi M. Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine. Am J Physiol Heart Circ Physiol. 2017;313(6):H1168–79.
Carrell TW, Burnand KG, Booth NA, Humphries J, Smith A. Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms. Vascular. 2006;14(1):9–16.
Thompson RW, Holmes DR, Mertens RA. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96(1):318–26.
Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovasc Surg. 2005;39(6):457–64.
Touat Z, Ollivier V, Dai J. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol. 2006;168(3):1022–30.
Swedenborg J, Eriksson P. The intraluminal thrombus as a source of proteolytic activity. Ann N Y Acad Sci. 2006;1085:133–8.
Nakagomi A. Effect of Toll-like receptor in periodontal bacteria-accelerated abdominal aortic aneurysms. Circ J. 2013;77(6):1414–5.
Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun. 1998;66(11):5337–43.
Deshpande RG, Khan M, Genco CA. Invasion strategies of the oral pathogen porphyromonas gingivalis: implications for cardiovascular disease. Invas Metastasis. 1998;18(2):57–69.
Hirose K, Isogai E, Ueda I. Porphyromonas gingivalis fimbriae induce adhesion of monocytic cell line U937 to endothelial cells. Microbiol Immunol. 2000;44(1):17–22.
Khlgatian M, Nassar H, Chou HH, Gibson FC, 3rdGenco CA. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun. 2002;70(1):257–67.
Nassar H, Chou HH, Khlgatian M, Gibson FC, 3rdVan Dyke TE, Genco CA. Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect Immun. 2002;70(1):268–76.
Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol. 2011;31(12):3011–9.
McCormick ML, Gavrila D, Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2007;27(3):461–9.